Device Trial Radar · NCT03972527
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
Last checked: Nov 19, 2026Latest source record: Aug 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
85
Actual
Start
Aug 5, 2022
Primary completion
Jun 26, 2024
Study completion Jul 18, 2024
Sponsor
- Lead sponsor
- MuReva Phototherapy Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 3, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall purpose of this clinical study is to evaluate safety and efficacy of the MuReva Phototherapy System with a light delivery mouthpiece to reduce the severity of oral mucositis (OM) in adult patients with squamous cell carcinoma of the oral cavity, oropharynx, tonsils and base of tongue receiving radiation therapy with or without concurrent chemotherapy.
Conditions
- Oral Mucositis (Ulcerative)
- Oral Mucositis (Ulcerative) Due to Radiation
- Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy
- Head and Neck Cancer
Interventions
PhotobiomodulationDevice
Provide photobiomodulation therapy to subjects prior to each radiation therapy session.
Routine Oral Care and AnalgesiaOther
Standard oral care, oral hygiene and oral pain protocols
Primary outcomes
What the sponsor says the trial is designed to measure.
- IThe primary effectiveness endpoint is the severity of oral mucositis at week 6 of radiation treatment according to the Oral Mucositis Index (OMI) score.Time frame: approximately 6 weeks after patient begins radiation therapy
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
The Oncology Institute
Long Beach, California
Miami Cancer Institute
Miami, Florida
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.